Esperion Therapeutics Inc (NASDAQ:ESPR)

38.23
BATS BZX Real-Time Price
As of 2:18pm ET
 -0.09 / -0.23%
Today’s Change
30.95
Today|||52-Week Range
82.68
-41.93%
Year-to-Date
No recent news for Esperion Therapeutics Inc.

Today’s Trading

Previous close38.32
Today’s open38.33
Day’s range37.65 - 39.13
Volume39,909
Average volume (3 months)1,089,538
Market cap$1.1B
Data as of 2:18pm ET, 05/24/2018

Growth & Valuation

Earnings growth (last year)-109.61%
Earnings growth (this year)+11.40%
Earnings growth (next 5 years)-42.11%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book4.39

Competitors

 Today’s
change
Today’s
% change
GBTGlobal Blood Therape...-0.10-0.21%
TXMDTherapeuticsMD Inc+0.17+2.86%
BHVNBiohaven Pharmaceuti...+0.73+2.18%
FWPForward Pharma A/S+0.38+13.01%
Data as of 2:21pm ET, 05/24/2018

Financials

Next reporting dateAugust 14, 2018
EPS forecast (this quarter)-$1.62
Annual revenue (last year)$0.00
Annual profit (last year)-$167.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Tim M. Mayleben
COO, Executive VP-Research &
Development
Narendra D. Lalwani
Corporate headquarters
Ann Arbor, Michigan

Forecasts